These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6927475)

  • 21. [Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].
    Scarazzati E; Catenazzo G; Melloni CF; Ghirardi P; Bianco L
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1631-5. PubMed ID: 6667307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ibopamine on peripheral haemodynamics.
    Longhini C; Musacci GF; Ansani L; Toselli T; Artioli M; Bianco L; Ghirardi P
    Eur J Clin Pharmacol; 1983; 24(5):585-9. PubMed ID: 6873134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy.
    Dei Cas L; Bolognesi R; Cucchini F; Fappani A; Riva S; Visioli O
    J Cardiovasc Pharmacol; 1983; 5(2):249-53. PubMed ID: 6188898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action.
    Hogg KJ; Hornung RS; Howie CA; Hillis WS
    Br J Clin Pharmacol; 1987 Oct; 24(4):435-42. PubMed ID: 3689625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dopamine congener, ibopamine, in congestive heart failure.
    Ren JH; Unverferth DV; Leier CV
    J Cardiovasc Pharmacol; 1984; 6(5):748-55. PubMed ID: 6209476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the cardiohemodynamic effects of ibopamine, an orally-active dopamine analogue, in the anesthetized open-chest guinea pig and the isolated guinea pig atria.
    Matsui K; Imai S
    Jpn J Pharmacol; 1986 Oct; 42(2):217-27. PubMed ID: 3795623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibopamine as a valuable adjunct and substitute for dopamine in bridging therapy before heart transplantation.
    Kleber FX; Sabin GV; Thyroff-Friesinger U; Cabell B; Glogar D
    Cardiology; 1992; 81(2-3):121-4. PubMed ID: 1286470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
    Melloni R; Scarazatti E; Gandini C; Melloni GF
    Boll Soc Ital Biol Sper; 1987 Dec; 63(12):1121-8. PubMed ID: 3331290
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of ibopamine on changes in renal hemodynamics experimentally induced in anesthetized dogs].
    Merlo L; Brusoni B; Mussini E; Ghirardi P
    Boll Soc Ital Cardiol; 1981; 26(11):1569-75. PubMed ID: 7349207
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of ibopamine in cardiac insufficiency in auricular fibrillation. Presentation of a case].
    Barriales V; Martínez Trabanco I; Richard JM; Cortina A
    Rev Clin Esp; 1989 Mar; 184(5):265. PubMed ID: 2772298
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological characterization of epinine 3-O-sulphate and 4-O-sulphate.
    Ferrini R; Merlo L; Miragoli G
    Arch Int Pharmacodyn Ther; 1987 Sep; 289(1):37-45. PubMed ID: 3435204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemodynamic effects induced by ibopamine in myocardiopathy patients].
    Dei Cas L; Cucchini F; Bolognesi R; Fappani A; Manca C; Riva S
    Cardiologia; 1982; 27(6):601-2. PubMed ID: 6234903
    [No Abstract]   [Full Text] [Related]  

  • 34. [Congestive cardiomyopathy: basal hemodynamics and hemodynamics after various positive inotropic drugs administered singly or in combinations].
    Cappello C; Fusaro MT; Mattioli G
    Cardiologia; 1988 Dec; 33(12):1127-32. PubMed ID: 3076518
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ibopamine, adrenolytic drugs and renal function].
    Agnoli GC; Borgatti R; Cacciari M; Dorigoni S; Garutti C; Ikonomu E; Lenzi P
    Minerva Cardioangiol; 1987 May; 35(5):241-50. PubMed ID: 2888053
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
    Rolandi E; Marchetti G; Franceschini R; Cicchetti V; Gianrossi R; Cantoni V; Barreca T
    Eur J Clin Pharmacol; 1986; 29(5):629-30. PubMed ID: 3956568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
    Sher D; Ferrari V
    Arzneimittelforschung; 1987 Jul; 37(7A):873-900. PubMed ID: 3675684
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation.
    Bernardi L; Perlini S; Soffiantino F; Farilla C; Calciati A; Soldá PL; Paro M; Merlo L; Marchetti G; Finardi G
    Eur J Pharmacol; 1989 May; 164(3):415-24. PubMed ID: 2767116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man.
    Dei Cas L; Manca C; Vasini G; Mansour M; Bernardini B; Visioli O
    Arzneimittelforschung; 1980; 30(3):498-500. PubMed ID: 7387762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of ibopamine on the pulmonary circulation and right ventricular performance in patients with chronic obstructive pulmonary disease.
    Skwarski K; Barratt A; MacNee W
    Cardiology; 1992; 80(5-6):349-55. PubMed ID: 1451122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.